Price$0.16-0.15 (-48.36%)
2026-03-042026-06-05
News · 26 weeks44+50%
2025-12-142026-06-07
Mix1290d
- SEC Filings6(50%)
- Insider3(25%)
- Market2(17%)
- Other1(8%)
Latest news
25 items- SECVSee Health Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity Securities, Leadership Update8-K - VSEE HEALTH, INC. (0001864531) (Filer)
- INSIDERCo-Chief Executive Officer Chen Milton disposed of 2,870,069 shares, closing all direct ownership in the company (SEC Form 4)4 - VSEE HEALTH, INC. (0001864531) (Issuer)
- SECSEC Form 424B3 filed by VSee Health Inc.424B3 - VSEE HEALTH, INC. (0001864531) (Filer)
- SECSEC Form 10-Q filed by VSee Health Inc.10-Q - VSEE HEALTH, INC. (0001864531) (Filer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by VSee Health Inc.SCHEDULE 13G/A - VSEE HEALTH, INC. (0001864531) (Subject)
- SECSEC Form POS EX filed by VSee Health Inc.POS EX - VSEE HEALTH, INC. (0001864531) (Filer)
- SECSEC Form 424B3 filed by VSee Health Inc.424B3 - VSEE HEALTH, INC. (0001864531) (Filer)
- NEWSVSee Health Reports 2025 Financial Results: Revenue Grows 40% Year-over-Year with a Strong Year End Balance SheetSAN JOSE, CA / ACCESS Newswire / April 1, 2026 / VSee Health, Inc. (NASDAQ:VSEE), a leader in AI-powered telehealth technology and high-acuity virtual care solutions, today reported its financial and operational results for the full year ended December 31, 2025. The Company delivered strong top-line growth and meaningful margin improvement while significantly narrowing its net loss.Key Financial Highlights (Year-over-Year Comparisons)Revenue increased 40% to $14,618,184 in 2025 from $10,421,352 in 2024Gross margin rose 2% to $7,355,965 from $7,177,580Operating expenses declined sharply by 76%The Company strengthened its balance sheet through multiple debt to equity conversionsCash and liquid
- SECSEC Form 10-K filed by VSee Health Inc.10-K - VSEE HEALTH, INC. (0001864531) (Filer)
- INSIDERSEC Form 4 filed by Leonard Jerry4 - VSEE HEALTH, INC. (0001864531) (Issuer)
- INSIDERSEC Form 4 filed by Aisiku Imoigele4 - VSEE HEALTH, INC. (0001864531) (Issuer)
- NEWSVSee Unveils World's First Autonomous Telehealth AI Robot at HIMSS 2026Autonomous, AI-Powered Robot Navigates Directly to Patients' Bedsides - No Staff Escort RequiredLAS VEGAS, NV / ACCESS Newswire / March 10, 2026 / VSee (NASDAQ:VSEE), the leader in telehealth platform innovation, today announced the launch of the VSee AI Robot at HIMSS 2026 - the world's first fully autonomous telehealth AI robot purpose-built for hospital and health system deployment. The VSee AI Robot enables remote clinicians to navigate directly to a patient's bedside without requiring onsite staff assistance, delivering true virtual rounding, rapid telestroke response, and specialist coverage across emergency departments and ICUs at scale.The launch marks a pivotal inflection point in c
- INSIDERDirector O'Sullivan Colin P. was granted 40,107 shares, increasing direct ownership by 58% to 108,731 units (SEC Form 4)4 - VSEE HEALTH, INC. (0001864531) (Issuer)
- INSIDERDirector Metzger Scott was granted 40,107 shares, increasing direct ownership by 52% to 117,356 units (SEC Form 4)4 - VSEE HEALTH, INC. (0001864531) (Issuer)
- INSIDERDirector Lowdermilk Kevin was granted 40,107 shares, increasing direct ownership by 58% to 108,731 units (SEC Form 4)4 - VSEE HEALTH, INC. (0001864531) (Issuer)
- INSIDERDirector Wickersham David L. was granted 40,107 shares, increasing direct ownership by 3% to 1,187,671 units (SEC Form 4)4 - VSEE HEALTH, INC. (0001864531) (Issuer)
- INSIDERDirector Fairfax Cydonii V. was granted 40,107 shares, increasing direct ownership by 59% to 108,504 units (SEC Form 4)4 - VSEE HEALTH, INC. (0001864531) (Issuer)
- SECSEC Form 424B3 filed by VSee Health Inc.424B3 - VSEE HEALTH, INC. (0001864531) (Filer)
- SECVSee Health Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - VSEE HEALTH, INC. (0001864531) (Filer)
- INSIDERDirector Wickersham David L. converted options into 865,167 shares (SEC Form 4)4 - VSEE HEALTH, INC. (0001864531) (Issuer)
- SECVSee Health Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits8-K - VSEE HEALTH, INC. (0001864531) (Filer)
- INSIDERDirector Wickersham David L. acquired $200,000 worth of shares (100,000 units at $2.00), increasing direct ownership by 88% to 214,000 units (SEC Form 4)4 - VSEE HEALTH, INC. (0001864531) (Issuer)
- INSIDERCo-Chief Executive Officer Aisiku Imoigele disposed of $250,000 worth of shares (125,000 units at $2.00) (SEC Form 4)4 - VSEE HEALTH, INC. (0001864531) (Issuer)
- SECSEC Form SCHEDULE 13G filed by VSee Health Inc.SCHEDULE 13G - VSEE HEALTH, INC. (0001864531) (Subject)
- SECSEC Form DEFA14A filed by VSee Health Inc.DEFA14A - VSEE HEALTH, INC. (0001864531) (Filer)
VSEE FAQ
6 questionsWhere does VSEE stock trade?
VSee Health Inc. (VSEE) is listed on NASDAQ.What sector and industry is VSEE in?
VSee Health Inc. operates in the Health Care sector, Medical/Nursing Services industry.When did VSee Health Inc. go public?
VSee Health Inc. (VSEE) completed its IPO in 2021.What are analysts saying about VSEE?
VSee Health Inc. has had 1 recent analyst action on file. The most recent action was from Maxim Group: Buy with a $500.00 price target on 2025-02-24. Recent price targets cluster around $500.00.What companies are similar to VSEE?
Notable peers in the same industry include BTSG (BrightSpring Health Services Inc.), HIMS (Hims & Hers Health Inc.), CHE (Chemed Corp), AMED (Amedisys Inc), LHCG (LHC Group). Compare VSEE side-by-side with any of them on Quantisnow.How can I track VSEE on Quantisnow?
Quantisnow aggregates VSee Health Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow VSEE to receive live email and push alerts on every new disclosure.